Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression
Pharmacists should consider GLP-1 receptor agonists as second-line agents in older adults with DKD when additional glycemic control is needed.
Researchers Evaluate Infection Control Challenges During an RSV Outbreak in a Cognitively Impaired Population
RSV poses a serious risk to older adults in long-term care, highlighting the need for effective outbreak management and infection…
Beyond Pain Control: Understanding and Managing Opioid-Induced Constipation
Discover effective strategies for managing opioid-induced constipation, including the role of PAMORAs and pharmacist involvement in pain management.
Headache or Harm: A Pharmacist’s Role in Differentiating Complement Inhibitor Adverse Effects
Pharmacists play a crucial role in managing headaches in patients on complement inhibitors for PNH, ensuring proper education and risk…
Who, When, and How: Navigating Combination Therapies in mCRC
Panelists discuss how managing common toxicities in combination therapies requires specific strategies including dose reductions and growth factor support for…
FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks
The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management…
Beyond Survival: SUNLIGHT’s Influence on QoL in mCRC
Panelists discuss how the SUNLIGHT trial’s demonstration that adding bevacizumab to trifluridine/tipiracil improves overall survival and progression-free survival represents the…
FDA Grants Birelentinib Fast Track Designation for Patients With Relapsed or Refractory CLL/SLL
Birelentinib gains FDA fast track designation, offering hope for relapsed CLL/SLL patients resistant to current BTK and BCL-2 therapies.
Caffeine Consumption Not Associated With Chronic Kidney Disease, Study Finds
The researchers speculate that this is because of the antioxidant and anti-inflammatory properties of coffee and tea.
Larazotide Safe, Effective in Children With COVID-19-Related MIS-C
Designed for use in Celiac disease, larazotide was found to hasten resolution of multisystem inflammatory syndrome symptoms in children with…